Project Number MR/P019366/1 Agency/Funding Organization United Kingdom - Medical Research Council Funding Year 2017 View Full Project Details for MICA Pharmacological, molecular and cellular mechanisms of muscarinic slowing (modification) of neurodegenerative disease. Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) i. Proteostasis/Proteinopathies Researcher and Organization Principal Investigator Tobin, Andrew Principal Investigator First Name Tobin Principal Investigator Last Name Andrew Awardee Organization University of Glasgow Contact PI Country United Kingdom Project Detail FY Overall Cost $1,058,862 Funding Organization Agency/Funding Organization United Kingdom - Medical Research Council Funding Organization Country United Kingdom
